Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manhay, officially Nanjing Manhay Medical Technology Co., Ltd., is a China-based healthcare and nutraceutical ingredients company focused on the research, production, and sale of plant active ingredients, botanical extracts, and certain microbial fermentation products. The company appears to operate primarily as a commercial supplier rather than a therapeutic drug developer, serving customers in health nutrition, cosmetic raw materials, and related life-science ingredient markets. Its website highlights products such as 3,3'-diindolylmethane, N-acetylneuraminic acid, N-acetyl-D-glucosamine, and L-carnosine, alongside capabilities in extraction, separation, testing, and OEM services. Manhay presents itself as an export-oriented private enterprise with GMP-oriented manufacturing and quality-control capabilities, including cooperation with a specialized phytochemistry laboratory. Based on available information, the company is best characterized as an active commercial health-ingredient and botanical-extract supplier with international export activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manhay.